D. E. Shaw & Co., Inc. Paratek Pharmaceuticals, Inc. Transaction History

D. E. Shaw & Co., Inc.

$107 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$1.52 - $2.8 $64,717 - $119,215	42,577 Added 12.04%	396,076 $875,000
Q1 2023 May 15, 2023	SELL	$1.37 - $2.54 $53,699 - $99,560	-39,197 Reduced 9.98%	353,499 $897,000
Q4 2022 Feb 14, 2023	BUY	$1.67 - $2.51 $138,830 - $208,661	83,132 Added 26.85%	392,696 $734,000
Q3 2022 Nov 14, 2022	BUY	$1.96 - $2.93 $375,055 - $560,670	191,355 Added 161.88%	309,564 $795,000
Q2 2022 Aug 15, 2022	BUY	$1.73 - $3.09 $71,410 - $127,549	41,278 Added 53.66%	118,209 $228,000
Q1 2022 May 16, 2022	BUY	$2.94 - $4.77 $142,642 - $231,430	48,518 Added 170.76%	76,931 $228,000
Q4 2021 Feb 14, 2022	SELL	$4.07 - $5.3 $110,272 - $143,598	-27,094 Reduced 48.81%	28,413 $128,000
Q3 2021 Nov 15, 2021	SELL	$4.7 - $7.24 $241,584 - $372,143	-51,401 Reduced 48.08%	55,507 $270,000
Q2 2021 Aug 16, 2021	SELL	$6.81 - $10.93 $747,363 - $1.2 Million	-109,745 Reduced 50.65%	106,908 $729,000
Q1 2021 May 17, 2021	SELL	$6.14 - $8.31 $1.1 Million - $1.49 Million	-179,008 Reduced 45.24%	216,653 $1.53 Million
Q4 2020 Feb 16, 2021	SELL	$4.58 - $7.14 $1 Million - $1.56 Million	-218,893 Reduced 35.62%	395,661 $2.48 Million
Q3 2020 Nov 16, 2020	SELL	$4.19 - $6.69 $1.69 Million - $2.7 Million	-403,911 Reduced 39.66%	614,554 $3.33 Million
Q2 2020 Aug 14, 2020	BUY	$2.97 - $5.22 $1.36 Million - $2.39 Million	457,341 Added 81.5%	1,018,465 $5.32 Million
Q1 2020 May 15, 2020	BUY	$2.67 - $4.97 $803,779 - $1.5 Million	301,041 Added 115.75%	561,124 $1.77 Million
Q4 2019 Feb 14, 2020	BUY	$2.93 - $4.5 $709,244 - $1.09 Million	242,063 Added 1343.3%	260,083 $1.05 Million
Q3 2019 Nov 14, 2019	BUY	$3.08 - $5.76 $55,501 - $103,795	18,020 New	18,020 $78,000
Q1 2018 May 15, 2018	SELL	$12.65 - $18.85 $253,898 - $378,338	-20,071 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$17.45 - $25.6 $350,238 - $513,817	20,071	20,071 $359,000

Others Institutions Holding PRTK

# of Institutions

Shares Held

1.54M

Call Options Held

Put Options Held

View Full List

About Paratek Pharmaceuticals, Inc.

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

More about PRTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account